{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T18:46:35Z","timestamp":1769625995834,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["12R2119N"],"award-info":[{"award-number":["12R2119N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.xphs.2018.10.041","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T14:02:33Z","timestamp":1541167353000},"page":"305-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Application of a Dynamic Fluid and pH Model to Simulate Intraluminal and Systemic Concentrations of a Weak Base in GastroPlus\u2122"],"prefix":"10.1016","volume":"108","author":[{"given":"Bart","family":"Hens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Bolger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2018.10.041_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2016.03.009","article-title":"Navigating the human gastrointestinal tract for oral drug delivery: uncharted waters and new frontiers","volume":"101","author":"Koziolek","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"issue":"2-3","key":"10.1016\/j.xphs.2018.10.041_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejps.2003.10.003","article-title":"The use of formulation technology to assess regional gastrointestinal drug absorption in humans","volume":"21","author":"Basit","year":"2004","journal-title":"Eur J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2018.10.041_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2036.2005.02683.x","article-title":"Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging","volume":"22","author":"Schiller","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.xphs.2018.10.041_bib4","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/mp500210c","article-title":"Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state","volume":"11","author":"Mudie","year":"2014","journal-title":"Mol Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2018.10.041_bib5","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1002\/jps.24183","article-title":"Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: a critical evaluation of the available data","volume":"103","author":"Fuchs","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2018.10.041_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0939-6411(00)00091-6","article-title":"Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards","volume":"50","author":"L\u00f6benberg","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"issue":"12","key":"10.1016\/j.xphs.2018.10.041_bib7","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1002\/jps.22217","article-title":"The developability classification system: application of biopharmaceutics concepts to formulation development","volume":"99","author":"Butler","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2018.10.041_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A\u00a0theoretical basis for a biopharmaceutic drug classification: the correlation of in\u00a0vitro drug product dissolution and in\u00a0vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2018.10.041_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.23359","article-title":"The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development","volume":"102","author":"Benet","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.10.041_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejps.2013.08.024","article-title":"In\u00a0vitro models for the prediction of in\u00a0vivo performance of oral dosage forms","volume":"57","author":"Kostewicz","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2018.10.041_bib11","article-title":"In\u00a0vitro methods to assess drug precipitation in the fasted small intestine\u2013a PEARRL review","author":"O\u2019Dwyer","year":"2018","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2018.10.041_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2018.06.050","article-title":"Formulation predictive dissolution (fPD) testing to advance oral drug product development: an introduction to the US FDA funded \u201c21st Century BA\/BE\u201d project","volume":"548","author":"Hens","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.10.041_bib13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejps.2013.09.008","article-title":"PBPK models for the prediction of in\u00a0vivo performance of oral dosage forms","volume":"57","author":"Kostewicz","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2018.10.041_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","article-title":"Physiologically-based pharmacokinetics in drug development and regulatory science","volume":"51","author":"Rowland","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"Suppl 1","key":"10.1016\/j.xphs.2018.10.041_bib15","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0169-409X(01)00179-X","article-title":"Predicting the impact of physiological and biochemical processes on oral drug bioavailability","volume":"50","author":"Agoram","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.041_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-5173(99)00147-7","article-title":"A\u00a0compartmental absorption and transit model for estimating oral drug absorption","volume":"186","author":"Yu","year":"1999","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2018.10.041_bib17","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/jps.24690","article-title":"Supersaturation and precipitation of posaconazole upon entry in the upper small intestine in humans","volume":"105","author":"Hens","year":"2016","journal-title":"J\u00a0Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2018.10.041_bib18","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/AAC.02686-13","article-title":"Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease","volume":"58","author":"Maertens","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.xphs.2018.10.041_bib20","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1021\/acs.molpharmaceut.7b00396","article-title":"In silico modeling approach for the evaluation of gastrointestinal dissolution, supersaturation, and precipitation of posaconazole","volume":"14","author":"Hens","year":"2017","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2018.10.041_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0045-6535(02)00118-2","article-title":"Estimation of aqueous solubility of organic compounds by using the general solubility equation","volume":"48","author":"Ran","year":"2002","journal-title":"Chemosphere"},{"key":"10.1016\/j.xphs.2018.10.041_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejps.2013.08.027","article-title":"A\u00a0review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption","volume":"57","author":"Augustijns","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2018.10.041_bib23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/11592630-000000000-00000","article-title":"Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations","volume":"50","author":"Walravens","year":"2011","journal-title":"Clin Pharmacokinet"},{"issue":"7","key":"10.1016\/j.xphs.2018.10.041_bib24","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/AAC.01407-09","article-title":"Intracellular concentrations of posaconazole in different compartments of peripheral blood","volume":"54","author":"Farowski","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.041_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/dmd.32.2.267","article-title":"Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of posaconazole (Noxafil)","volume":"32","author":"Ghosal","year":"2004","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.xphs.2018.10.041_bib26","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s11095-011-0506-6","article-title":"Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults","volume":"28","author":"Psachoulias","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2018.10.041_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2014.07.008","article-title":"Gastrointestinal transfer: in\u00a0vivo evaluation and implementation in in\u00a0vitro and in silico predictive tools","volume":"63","author":"Hens","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2018.10.041_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejpb.2018.05.033","article-title":"Gastric emptying and intestinal appearance of nonabsorbable drugs phenol red and paromomycin in human subjects: a multi-compartment stomach approach","volume":"129","author":"Paix\u00e3o","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"10.1016\/j.xphs.2018.10.041_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrgastro.2012.57","article-title":"The migrating motor complex: control mechanisms and its role in health and disease","volume":"9","author":"Deloose","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.041_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","article-title":"Population-based mechanistic prediction of oral drug absorption","volume":"11","author":"Jamei","year":"2009","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.041_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0939-6411(97)00088-X","article-title":"Saturable small intestinal drug absorption in humans: modeling and interpretation of cefatrizine data","volume":"45","author":"Yu","year":"1998","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2018.10.041_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejps.2013.05.019","article-title":"In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim","volume":"49","author":"Sj\u00f6gren","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2018.10.041_bib33","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1002\/jps.22726","article-title":"Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions","volume":"100","author":"Thelen","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2018.10.041_bib34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.2042-7158.2012.01534.x","article-title":"Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim\u00ae","volume":"64","author":"Willmann","year":"2012","journal-title":"J\u00a0Pharm Pharmacol"},{"issue":"16","key":"10.1016\/j.xphs.2018.10.041_bib35","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1021\/jm030999b","article-title":"A\u00a0physiological model for the estimation of the fraction dose absorbed in humans","volume":"47","author":"Willmann","year":"2004","journal-title":"J\u00a0Med Chem"},{"issue":"6","key":"10.1016\/j.xphs.2018.10.041_bib36","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1208\/s12248-017-0145-x","article-title":"Mechanistic fluid transport model to estimate gastrointestinal fluid volume and its dynamic change over time","volume":"19","author":"Yu","year":"2017","journal-title":"AAPS J"},{"issue":"6","key":"10.1016\/j.xphs.2018.10.041_bib37","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1021\/acs.molpharmaceut.7b01077","article-title":"Pulse packet stochastic model for gastric emptying in the fasted state: a physiological approach","volume":"15","author":"Talattof","year":"2018","journal-title":"Mol Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2018.10.041_bib38","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/acs.molpharmaceut.5b00861","article-title":"In silico modeling of gastrointestinal drug absorption: predictive performance of three physiologically based absorption models","volume":"13","author":"Sj\u00f6gren","year":"2016","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.xphs.2018.10.041_bib39","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.xphs.2017.04.030","article-title":"Osmolality of orally administered solutions influences luminal water volume and drug absorption in intestine","volume":"106","author":"Ichijo","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2018.10.041_bib40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2982.2007.01061.x","article-title":"Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy","volume":"20","author":"Cassilly","year":"2008","journal-title":"Neurogastroenterol Motil"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918306737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918306737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:26:53Z","timestamp":1758360413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918306737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0022354918306737"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.10.041","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of a Dynamic Fluid and pH Model to Simulate Intraluminal and Systemic Concentrations of a Weak Base in GastroPlus\u2122","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.10.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}